{
  "ingredient": {
    "name": "Akkermansia muciniphila",
    "slug": "akkermansia-muciniphila",
    "category": "probiotic",
    "description": "Next-generation probiotic with mucin degradation and barrier benefits",
    "gut_score": 8.0,
    "confidence_score": 0.8,
    "aliases": [
      "A. muciniphila",
      "Akkermansia"
    ],
    "dosage_info": {
      "min_dose": "10000000000.0",
      "max_dose": "10000000000",
      "unit": "CFU",
      "frequency": "daily"
    }
  },
  "microbiome_effects": [
    {
      "bacteria_name": "Mucin layer",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "strong",
      "confidence": 0.7,
      "mechanism": "Enhances mucin degradation and barrier function through specialized metabolism"
    },
    {
      "bacteria_name": "GLP-1 secretion",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "strong",
      "confidence": 0.7,
      "mechanism": "Reduces intestinal permeability and modulates immune response through TLR2/TLR4 pathways"
    }
  ],
  "metabolic_effects": [
    {
      "effect_name": "improves_barrier_function",
      "effect_category": "metabolism",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "mechanism": "Improves insulin sensitivity and reduces insulinemia through gut barrier enhancement"
    }
  ],
  "symptom_effects": [
    {
      "symptom_name": "irregular_bowel",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "population_notes": "Reduces metabolic syndrome markers and improves liver function with decreased inflammation"
    }
  ],
  "citations": [
    {
      "pmid": "31263284",
      "title": "Supplementation with Akkermansia muciniphila",
      "authors": "Research Team",
      "journal": "Nature Medicine",
      "publication_year": 2019,
      "study_type": "clinical"
    }
  ]
}